UroGen Pharma Ltd. (URGN)
28.89
-0.99
(-3.31%)
USD |
NASDAQ |
May 22, 16:00
28.87
-0.02
(-0.07%)
After-Hours: 20:00
UroGen Pharma Total Assets (Quarterly) : 253.69M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Cogent Biosciences, Inc. | 903.01M |
| BioCryst Pharmaceuticals, Inc. | 465.05M |
| United Therapeutics Corp. | 6.714B |
| Puma Biotechnology, Inc. | 192.70M |
| TG Therapeutics, Inc. | 1.529B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 377.94M |
| Shareholders Equity (Quarterly) | -124.25M |
| Debt to Equity Ratio | -1.586 |
| Current Ratio | 4.690 |
| Net Debt Paydown Yield | -1.65% |